{
    "organizations": [],
    "uuid": "6ef3ef34722b3c51b72a9a3936ba0a7a53bc2d3d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-takeda-says-notes-statement-by-shi/brief-takeda-says-notes-statement-by-shire-regarding-revised-proposal-deadline-extension-idUST9N1QY01V",
    "ord_in_thread": 0,
    "title": "BRIEF-Takeda Says Notes Statement By Shire Regarding Revised Proposal, Deadline Extension",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - Japanâ€™s Takeda Pharmaceutical Co Ltd :\n* SAYS NOTES STATEMENT BY SHIRE PLC REGARDING REVISED PROPOSAL AND EXTENSION OF PUSU DEADLINE TO MAY 8, 2018\n* SAYS INTENDS TO MAINTAIN ITS WELL-ESTABLISHED DIVIDEND POLICY AND INVESTMENT GRADE CREDIT RATING Source text for Eikon: Further company coverage: (Reporting By Chris Gallagher)\n ",
    "published": "2018-04-25T08:33:00.000+03:00",
    "crawled": "2018-04-25T14:21:53.025+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "japan",
        "takeda",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "note",
        "statement",
        "shire",
        "plc",
        "regarding",
        "revised",
        "proposal",
        "extension",
        "pusu",
        "deadline",
        "may",
        "say",
        "intends",
        "maintain",
        "dividend",
        "policy",
        "investment",
        "grade",
        "credit",
        "rating",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "chris",
        "gallagher"
    ]
}